Raloxifene for older women: a review of the literature
Helga HansdóttirDepartment of Geriatrics, Landspitali University Hospital, Landakoti, Reykjavik, IcelandAbstract: Raloxifene is a non-steroidal selective estrogen-receptor modulator (SERM) which is used for prevention and treatment of postmenopausal osteoporosis. Raloxifene decreases the...
Guardado en:
Autor principal: | Helga Hansdóttir |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6bc9696e6b4b436ba926d8eb3399efcb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014) -
Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Esteban Jódar-Gimeno
Publicado: (2007) -
Falls in the community-dwelling older adult: A review for primary-care providers
por: Theresa A Soriano, et al.
Publicado: (2008) -
Factors Associated for Mortality of Older People With COVID 19: A Systematic Review and Meta-analysis
por: H. D. W. T. Damayanthi BScN, MSc, MSN, PhD, et al.
Publicado: (2021) -
Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
por: Victor G Vogel
Publicado: (2008)